Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations
- PMID: 16014653
- DOI: 10.1093/brain/awh590
Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations
Abstract
We describe clinical, electrophysiological, histopathological and molecular features of a unique disease caused by mutations in the glycyl-tRNA synthetase (GARS) gene. Sixty patients from five multigenerational families have been evaluated. The disease is characterized by adolescent onset of weakness, and atrophy of thenar and first dorsal interosseus muscles progressing to involve foot and peroneal muscles in most but not all cases. Mild to moderate sensory deficits develop in a minority of patients. Neurophysiologically confirmed chronic denervation in distal muscles with reduced compound motor action potentials were features consistent with both motor neuronal and axonal pathology. Sural nerve biopsy showed mild to moderate selective loss of small- and medium-sized myelinated and small unmyelinated axons, although sensory nerve action potentials were not significantly decreased. Based on the presence or absence of sensory changes, the disease phenotype was initially defined as distal spinal muscular atrophy type V (dSMA-V) in three families, Charcot-Marie-Tooth disease type 2D (CMT2D) in a single family, and as either dSMA-V or CMT2D in patients of another large family. Linkage to chromosome 7p15 and the presence of disease-associated heterozygous GARS mutations have been identified in patients from each of the five studied families. We conclude that patients with GARS mutations present a clinical continuum of predominantly motor distal neuronopathy/axonopathy with mild to moderate sensory involvement that varies between the families and between members of the same family. Awareness of these overlapping clinical phenotypes associated with mutations in GARS will facilitate identification of this disorder in additional families and direct future research toward better understanding of its pathogenesis.
Similar articles
-
The G526R glycyl-tRNA synthetase gene mutation in distal hereditary motor neuropathy type V.Neurology. 2006 Jun 13;66(11):1721-6. doi: 10.1212/01.wnl.0000218304.02715.04. Neurology. 2006. PMID: 16769947
-
Autosomal recessive axonal Charcot-Marie-Tooth disease (ARCMT2): phenotype-genotype correlations in 13 Moroccan families.Brain. 2007 Apr;130(Pt 4):1062-75. doi: 10.1093/brain/awm014. Epub 2007 Mar 8. Brain. 2007. PMID: 17347251
-
Clinical and pathological phenotype of the original family with Charcot-Marie-Tooth type 1B: a 20-year study.Ann Neurol. 1997 Apr;41(4):463-9. doi: 10.1002/ana.410410409. Ann Neurol. 1997. PMID: 9124803
-
[Molecular genetics of inherited neuropathies].Rinsho Shinkeigaku. 2006 Jan;46(1):1-18. Rinsho Shinkeigaku. 2006. PMID: 16541790 Review. Japanese.
-
Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients.Brain. 2007 Dec;130(Pt 12):3250-64. doi: 10.1093/brain/awm271. Brain. 2007. PMID: 18055494 Review.
Cited by
-
To charge or not to charge: mechanistic insights into neuropathy-associated tRNA synthetase mutations.Curr Opin Genet Dev. 2013 Jun;23(3):302-9. doi: 10.1016/j.gde.2013.02.002. Epub 2013 Mar 4. Curr Opin Genet Dev. 2013. PMID: 23465884 Free PMC article. Review.
-
Overlapping spectrums: The clinicogenetic commonalities between Charcot-Marie-Tooth and other neurodegenerative diseases.Brain Res. 2020 Jan 15;1727:146532. doi: 10.1016/j.brainres.2019.146532. Epub 2019 Oct 31. Brain Res. 2020. PMID: 31678418 Free PMC article. Review.
-
An Integrated Approach to Studying Rare Neuromuscular Diseases Using Animal and Human Cell-Based Models.Front Cell Dev Biol. 2022 Jan 3;9:801819. doi: 10.3389/fcell.2021.801819. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35047510 Free PMC article. Review.
-
A Mitochondrial tRNA Mutation Causes Axonal CMT in a Large Venezuelan Family.Ann Neurol. 2020 Oct;88(4):830-842. doi: 10.1002/ana.25854. Epub 2020 Aug 29. Ann Neurol. 2020. PMID: 32715519 Free PMC article.
-
Dominant, toxic gain-of-function mutations in gars lead to non-cell autonomous neuropathology.Hum Mol Genet. 2015 Aug 1;24(15):4397-406. doi: 10.1093/hmg/ddv176. Epub 2015 May 13. Hum Mol Genet. 2015. PMID: 25972375 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical